Lv41
540 积分 2025-01-06 加入
Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression
1小时前
已完结
Bortezomib plus dexamethasone for rituximab-resistant PLA2R+ membranous nephropathy
1小时前
已完结
Plasma Cell-Directed Rescue with Bortezomib in Refractory PLA2R-Positive Membranous Nephropathy
1小时前
已完结
Peptide GAM immunoadsorption in anti‐PLA2R positive autoimmune membranous nephropathy. The PRISM trial
1小时前
已完结
Anti-PLA2R1 IgG-mediated podocyte PLA2R1 cleavage drives glomerular subepithelial immune complex deposition in membranous nephropathy
4天前
已完结
Antibodies and complement are key drivers of thrombosis
1个月前
已完结
Functionally distinct anticoagulant mechanisms of endothelial cells
1个月前
已完结
Complement activation and effector pathways in membranous nephropathy
1个月前
已完结
Determining the effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration in rat plasma samples
2个月前
已完结
Retrospective Analysis of a Novel Regimen for the Prevention of Venous Thromboembolism in Nephrotic Syndrome
4个月前
已完结
皖公网安备34019202002308
